Literature DB >> 7970733

Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice.

J M Lee1, J L Abrahamson, R Kandel, L A Donehower, A Bernstein.   

Abstract

The p53 tumour suppressor gene is an important participant in the cellular response to ionizing radiation and other DNA damaging agents. Cells which lack p53 are unable to arrest cell cycle or enter into apoptotic cell death following irradiation. Moreover, these p53 deficient cells exhibit an increased resistance to DNA damaging agents, including radiation. The significance of this radiation-resistance and its relationship to the role that p53 plays in tumour suppression and the cellular radiation response has not yet been determined. In this report we have analyzed p53 deficient mice, expressing either a mutant p53 transgene or having a targeted p53 null allele, in order to investigate the role that p53 plays in governing susceptibility to radiation-carcinogenesis and in controlling the in vivo accumulation of chromosomal abnormalities. We show that wild-type p53 plays a critical role in controlling susceptibility to gamma-radiation-induced tumorigenesis, and sarcomas and lymphomas rapidly appear in irradiated p53 transgenic mice. Moreover, this susceptibility to radiation-carcinogenesis is associated with a two-fold increase in the in vivo accumulation of radiation-induced double stranded chromosomal breaks relative to that observed in wild-type animal. Taken together, these observations suggest that p53 acts to suppress tumour formation in vivo by preventing the accumulation of cells that have sustained radiation-induced DNA damage.

Entities:  

Mesh:

Year:  1994        PMID: 7970733

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice.

Authors:  C Conde; M Mark; F J Oliver; A Huber; G de Murcia; J Ménissier-de Murcia
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Genetically engineered mouse models for studying radiation biology.

Authors:  Katherine D Castle; Mark Chen; Amy J Wisdom; David G Kirsch
Journal:  Transl Cancer Res       Date:  2017-07       Impact factor: 1.241

Review 3.  Smoking, p53 mutation, and lung cancer.

Authors:  Don L Gibbons; Lauren A Byers; Jonathan M Kurie
Journal:  Mol Cancer Res       Date:  2014-01       Impact factor: 5.852

Review 4.  The role of p53 in human cancer.

Authors:  D Malkin
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor.

Authors:  J L Abrahamson; J M Lee; A Bernstein
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

6.  p53 deficiency does not affect the accumulation of point mutations in a transgene target.

Authors:  A T Sands; M B Suraokar; A Sanchez; J E Marth; L A Donehower; A Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

7.  Krüppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage.

Authors:  Hong S Yoon; Amr M Ghaleb; Mandayam O Nandan; Irfan M Hisamuddin; William Brian Dalton; Vincent W Yang
Journal:  Oncogene       Date:  2005-06-09       Impact factor: 9.867

8.  An extra copy of p53 suppresses development of spontaneous Kras-driven but not radiation-induced cancer.

Authors:  Everett J Moding; Hooney D Min; Katherine D Castle; Moiez Ali; Loretta Woodlief; Nerissa Williams; Yan Ma; Yongbaek Kim; Chang-Lung Lee; David G Kirsch
Journal:  JCI Insight       Date:  2016-07-07

Review 9.  Murine models of neoplasia: functional analysis of the tumour suppressor genes Rb-1 and p53.

Authors:  A R Clarke
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

Review 10.  Apoptosis, cancer and the p53 tumour suppressor gene.

Authors:  J M Lee; A Bernstein
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.